Evidence map›Paper›PMID 39548731›Full record

ArticleProtein science : a publication of the Protein Society2024

Disulfide-mediated oligomerization of mutant Cu/Zn-superoxide dismutase associated with canine degenerative myelopathy.

Yuki Shino, Norifumi Muraki, Yui Kobatake, Hiroaki Kamishina, Ryuichi Kato, Yoshiaki Furukawa

Abstract read
In one paragraph

Article in Protein science : a publication of the Protein Society, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yuki ShinoDepartment of Chemistry, Keio University, Yokohama, Japan.
Norifumi MurakiDepartment of Chemistry, Keio University, Yokohama, Japan.
Yui KobatakeJoint Department of Veterinary Medicine, Faculty of Applied Biological Science, Gifu University, Gifu, Japan.
Hiroaki KamishinaKyoto AR Advanced Veterinary Medical Center, Kyoto, Japan.
Ryuichi KatoStructural Biology Research Center, Photon Factory, Institute of Materials Structure Science, High Energy Accelerator Research Organization (KEK), Ibaraki, Japan.
Yoshiaki FurukawaDepartment of Chemistry, Keio University, Yokohama, Japan.

Funding

Exploratory Research Center on Life and Living Systems, National Institutes of Natural Sciences 23EXC334Japan Agency for Medical Research and Development JP21am0101083The Ministry of Education, Culture, Sports, Science and Technology (MEXT) 19H05765The Ministry of Education, Culture, Sports, Science and Technology (MEXT) 22H02768The Ministry of Education, Culture, Sports, Science and Technology (MEXT) 22K19389
6 · The paper itself

Abstract

A homozygous E40K mutation in the gene coding canine Cu/Zn-superoxide dismutase (cSOD1) causes degenerative myelopathy (DM) in dogs. A pathological hallmark of DM with the cSOD1 mutation is the aggregation of mutant cSOD1 proteins in neurons. The amino acid substitution E40K disrupts a salt bridge between Glu40 and Lys91 and is considered to destabilize the native state of cSOD1; however, the mechanism by which mutant cSOD1 aggregates remains unclear. Here, we show that mutant cSOD1 losing a copper and zinc ion forms oligomers crosslinked via disulfide bonds. The E40K substitution was found to result in the increased solvent exposure of the Cys7 side chain, which then attacked the disulfide bond (Cys57-Cys146) in cSOD1 to form disulfide-linked oligomers. We also successfully prevented the Cys7 exposure and thus the oligomerization of mutant cSOD1 by a fragment antibody that specifically recognizes the region around the mutation site. The fragment antibody covered the β-plug region, reinforcing the interactions compromised by the E40K substitution and thus contributing to the maintenance of the structural integrity of the β-barrel core of cSOD1. Taken together, we propose that the Cys7 exposure in cSOD1 upon the salt bridge disruption plays a central role in the aggregation mechanism of DM-associated mutant cSOD1.

Indexed as

DisulfidesSuperoxide Dismutase-1Amino Acid SubstitutionAnimalsCopperDog DiseasesDogsMutationMutation, MissenseProtein MultimerizationSpinal Cord DiseasesZincCopperDisulfidesSuperoxide Dismutase-1Zincamyotrophic lateral sclerosisantibodycanine degenerative myelopathycrystal structural analysisCu/Zn‐superoxide dismutaseprotein misfolding

Identifiers

PMID39548731
PMCPMC11568243

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.